Eos SENOLYTIX, .
Develops senolytic drugs to clear senescent cells and promote cellular rejuvenation.
About
Eos SENOLYTIX is a longevity biotechnology company developing novel gerotherapeutics that target the fundamental mechanisms of aging. Their lead candidate, PTC-2105, utilizes proprietary MitoXcelâ„¢ Technology to restore mitochondrial function and promote the clearance of senescent cells, aiming to improve healthspan and address age-related diseases. This context-dependent approach intervenes at the root cause of aging, mitochondrial dysfunction, to drive systemic improvements. Teams look it up for Biotech, MedTech, HealthTech.
Frequently asked
What does Eos SENOLYTIX, . do?
Eos SENOLYTIX, . is a Biotech company that offers Biotech. Teams look it up for MedTech, HealthTech, Longevity. It is based in Cambridge, United States and was founded in 2017. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
Where is Eos SENOLYTIX, . headquartered?
Eos SENOLYTIX, . is headquartered in Cambridge, United States.
When was Eos SENOLYTIX, . founded?
Eos SENOLYTIX, . was founded in 2017.
What industry does Eos SENOLYTIX, . operate in?
Eos SENOLYTIX, . operates in Biotech, MedTech, HealthTech, Longevity, Senolytics.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.